Immunomodulatory effect of a purified peptide fraction isolated from Mesobuthus eupeus scorpion venom on astrocytoma cell line (1321N1)

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 204

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PJMT-9-2_003

تاریخ نمایه سازی: 19 بهمن 1399

Abstract:

Objective(s): Multiple Sclerosis is a central nervous system disease which belongs to the category of autoimmune diseases. The prevalence of this disease in Iran is approaching the European level. Astrocyte cells are nerve tissues that regulate the immune system activity by secreting various cytokines such as IL- 17.  The aim of this study was partial purification of toxin from M.eupeus scorpion venom that has immunomodulatory effect on astrocyte cell line (1321N1) Materials and Methods: In the present study, purified crude venom of M.eupeus scorpion. Size exclusion and reverse-phase high-performance liquid chromatography was used for fractionation. The fractional molecular weight was determined by Using SDS and Tricine electrophoresis, Astrocyte cells (1321N1) were selected as functional cells in testing the immunomodulatory effect of venom. The viability of cells were determined by MTT and LDH assays. Astrocyte cells were activated by lipopolysaccharide and the release of interleukin-17 in activated cells was estimated using ELISA kit. Results:  fraction 331 (F331) from RP-HPLC contain the purified peptide with molecular weight of about 4500 Dalton. When activated cells exposed to purified peptide the rate of interleukin-17 release was found to be 85 pg/ml which is almost similar to un-activated cells (78 pg/ml). However in activated cells by LPS without treatment with purified peptide the rate of IL-17 release was found to be 147 pg/ml which was significantly (p <0.05) higher than control group.   Conclusion: The purified peptide (F331) from   venom of Mesobouthus eupeus can inactivate the astrocyte 1321N1 cells activated by LPS as indicated by decreased secretion of IL-17 from the cells.

Authors

- -

Biological Department, Faculty of science, Payame Noor University, Tehran

- -

Department of Venomous Animals and Antivenom Production, Razi Vaccine and Serum Research Institute, Agriculture Research Education and Extension Organization, Karaj, Iran

- -

Biological Department faculty of science, payame Noor University, Tehran, Iran

- -

Department of Biotechnology Venomous Animals and Antivenom Production, Razi Vaccine and Serum Research Institute, Agriculture Research Education and Extension Organization, Karaj, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1.  Swingler R, Compston D. The distribution of multiple sclerosis ...
  • 2.  Eskandarieh S, Heydarpour P, Elhami S-R, Sahraian MA. Prevalence ...
  • 3.  Frohman EM, Racke MK, Raine CS. Multiple sclerosis—the plaque ...
  • 4.            Correale J, Farez MF. The role of astrocytes in ...
  • 5.            Wolf F, Kirchhoff F. Imaging astrocyte activity. Science. 2008;320(5883):1597-9. ...
  • 6.            Volterra A, Meldolesi J. Astrocytes, from brain glue to ...
  • 7.            Hamberger AC, Chiang GH, Nylén ES, Scheff SW, Cotman ...
  • 8.            Yan SD, Bierhaus A, Nawroth PP, Stern DM. RAGE ...
  • 9.            Aschenbrenner DS. New Drug For Multiple Sclerosis. AJN The ...
  • 10.          Reid PF. Alpha-cobratoxin as a possible therapy for multiple ...
  • 11.          Hauser RA, Daguio M, Wester D, Hauser M, Kirchman ...
  • 12.          Mirshafiey A. Venom therapy in multiple sclerosis. Neuropharmacology. 2007;53(3):353-61. ...
  • 13.          Devaux J, Beeton C, Beraud E, Crest M. Ion ...
  • 14.          Batista CV, Gómez-Lagunas F, de la Vega RCRg, Hajdu ...
  • 15.          Gonzalez-Rosa JJ, Vazquez-Marrufo M, Vaquero E, Duque P, Borges ...
  • 16.          Croxford AL, Kurschus FC, Waisman A. Mouse models for ...
  • 17.          Srairi-Abid N, Guijarro JI, Benkhalifa R, Mantegazza M, Cheikh ...
  • 18.          Stankoff B, Aigrot M-S, Noël F, Wattilliaux A, Zalc ...
  • 19.          Namjooyan F, Ghanavati R, Majdinasab N, Jokari S, Janbozorgi ...
  • 20.          Dewi M, Rusmartini T, Sobandi A, Yuniarti L. The ...
  • 21.          Rioux P, Blier PU. Energetic metabolism and biochemical adaptation: ...
  • 22.          González‐Cruz J, Rodríguez‐Sotres R, Rodríguez‐Penagos M. On the convenience ...
  • 23.          Rudick R, Antel J, Confavreux C, Cutter G, Ellison ...
  • 24.          Holmøy T, Vartdal F. The immunological basis for treatment ...
  • 25.          Ciccarelli O, Barkhof F, Bodini B, De Stefano N, ...
  • 26.          Beckerman SR, Jimenez JE, Shi Y, Al-Ali H, Bixby ...
  • 27.          Kuzmenkov AI, Vassilevski AA, Kudryashova KS, Nekrasova OV, Peigneur ...
  • 28.          Bellot-Saez A, Kékesi O, Morley JW, Buskila Y. Astrocytic ...
  • 29.          Ortiz E, Gurrola GB, Schwartz EF, Possani LD. Scorpion ...
  • 30.          Wang T, Wang S-W, Zhang Y, Wu X-F, Peng ...
  • 31.          Gao B, Peigneur S, Tytgat J, Zhu S. A ...
  • نمایش کامل مراجع